TSPO and Parkinson disease: Terada et al. demonstrated similar elevated TSPO binding in the PD patients’ brains when using [11C]DPA-713 as a radioligand for the assessment [22], but not in the investigations using [18F]FEPPA performed by Koshimori et al. [23] and Ghadery et al. [24].